PFM Health Sciences’s Aramark ARMK Stock Holding History

PFM Health Sciences’s Portfolio ARMK Stock Details ARMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,045,039	Closed	-$23.9M	–	92
2015 Q1	$23.9M	Buy	+1,045,039	New	+$23.9M	0.66%	53

Other funds holding ARMK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

SIG

Senator Investment Group New York $2.74B AUM 55.95% 1-Year Est. Return

KCM

Kensico Capital Management Greenwich, Connecticut $5.83B AUM 42.34% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

PFM Health Sciences's ARMK Position: Q2 2015 in Review

PFM Health Sciences sold out of Aramark (ARMK) in Q2 2015, closing a stake of 1,045,039 shares — an estimated $23.9M sold.

PFM Health Sciences first reported a position in ARMK in Q1 2015 and held it in 1 quarter. The position peaked at $23.9M in Q1 2015. 222 funds tracked by Wall St. Rank hold ARMK as of Q2 2015.

PFM Health Sciences reported no remaining Aramark position as of Q2 2015 after selling out during the quarter.
PFM Health Sciences sold 1,045,039 Aramark shares in Q2 2015, an estimated $23.9M.
PFM Health Sciences first reported a position in Aramark in Q1 2015 and held it in 1 quarter.
PFM Health Sciences's Aramark position peaked at $23.9M in Q1 2015.
222 funds tracked by Wall St. Rank held Aramark as of Q2 2015.

Based on PFM Health Sciences's 13F filing for Q2 2015, filed 14 Aug 2015.